December 24, 2024.

ESG

Olympus Corporation (hereafter, Olympus) has been selected as a constituent of the Dow Jones Sustainability World Index (DJSI World), a leading global corporate sustainability evaluation Index. This marks the fourth consecutive selection for DJSI World. Additionally, Olympus has been selected as a constituent of the Dow Jones Sustainability Asia Pacific Index (DJSI Asia Pacific) for six consecutive years.

The Dow Jones Sustainability Index (DJSI) is a corporate sustainability evaluation Index related to MSCI ESG ETFs, co-developed by S&P Dow Jones Indices and RobecoSAM, which assesses corporate activities from three aspects: environmental, social, and governance, and selects companies with outstanding sustainability every year.

In 2024, 321 companies were selected for DJSI World from approximately 3,500 companies worldwide. In the 62 industry sectors, Olympus, belonging to the "Medical Devices" sector, was among the 7 out of 71 companies selected for DJSI World. This year, Olympus improved its scores in "tax reporting," "crisis management," and "labor practices," particularly in the areas of "climate change" and "materiality" compared to the previous year. In the "climate change" area, the short-term goals of the Olympus Group and the net-zero target received recognition from SBTi, while in "materiality," appropriate goal-setting and management of measures towards solving key issues were evaluated.

Comment from Company Executive, Representative Executive Officer, President, and ESG Officer Yasuo Takeuchi.

"We have established a new sustainability governance structure in April 2023 towards the next stage of achieving sustainable growth and have strengthened our efforts to address important ESG issues. The fourth consecutive selection for DJSI World is interpreted as an evaluation of these efforts, and we are very pleased. In the future, we will actively develop various initiatives to contribute to achieving a sustainable society for the realization of our purpose: 'the health and security of people around the world and the richness of their hearts.'"

Olympus Group's efforts in ESG.

For more details on ESG initiatives, please refer to our Integrated Report 2024 (PDF format: 6.9MB) and our Sustainability page.

In addition, our company is included in the ESG indexes such as DJSI, FTSE4Good Index Series, and FTSE Blossom Japan Index.

By the fiscal year ending March 2031, greenhouse gas emissions (Scope 1, 2) will be reduced by 70% from the 2020 baseline year.
By the fiscal year ending March 2028, 80% of our suppliers will have set science-based greenhouse gas reduction targets (based on emissions from purchased products and services, capital goods, and upstream trucking and distribution).

By 2040, achieve net zero greenhouse gas emissions (Scope 1, 2, 3) across the entire supply chain.

About Olympus

Olympus aims to achieve the health and safety of people worldwide and the richness of the heart, as stated in our "mission statement." As a world-leading medtech company, we will continue to contribute to improving the standard of medical care for targeted diseases by providing optimal solutions and services in early detection, diagnosis, and minimally invasive treatment in collaboration with healthcare professionals. For over 100 years since our founding, Olympus aims to contribute to society by delivering products that provide optimal value to customers around the globe. For more details, please visit Olympus's official website () and X (@Olympus_Corp_JP).